JP2005508363A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508363A5
JP2005508363A5 JP2003539685A JP2003539685A JP2005508363A5 JP 2005508363 A5 JP2005508363 A5 JP 2005508363A5 JP 2003539685 A JP2003539685 A JP 2003539685A JP 2003539685 A JP2003539685 A JP 2003539685A JP 2005508363 A5 JP2005508363 A5 JP 2005508363A5
Authority
JP
Japan
Prior art keywords
compound
mood disorder
composition
group
reuptake inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003539685A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005508363A (ja
JP4892654B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/034421 external-priority patent/WO2003037342A1/en
Publication of JP2005508363A publication Critical patent/JP2005508363A/ja
Publication of JP2005508363A5 publication Critical patent/JP2005508363A5/ja
Application granted granted Critical
Publication of JP4892654B2 publication Critical patent/JP4892654B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003539685A 2001-10-29 2002-10-29 デルタレセプターアゴニスト化合物によるうつ病の治療方法 Expired - Fee Related JP4892654B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34008401P 2001-10-29 2001-10-29
US60/340,084 2001-10-29
US33788701P 2001-11-02 2001-11-02
US60/337,887 2001-11-02
PCT/US2002/034421 WO2003037342A1 (en) 2001-10-29 2002-10-29 Method of treating depression with delta receptor agonist compounds

Publications (3)

Publication Number Publication Date
JP2005508363A JP2005508363A (ja) 2005-03-31
JP2005508363A5 true JP2005508363A5 (cg-RX-API-DMAC7.html) 2006-01-05
JP4892654B2 JP4892654B2 (ja) 2012-03-07

Family

ID=26990913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003539685A Expired - Fee Related JP4892654B2 (ja) 2001-10-29 2002-10-29 デルタレセプターアゴニスト化合物によるうつ病の治療方法

Country Status (11)

Country Link
US (1) US7030124B2 (cg-RX-API-DMAC7.html)
EP (1) EP1450807B1 (cg-RX-API-DMAC7.html)
JP (1) JP4892654B2 (cg-RX-API-DMAC7.html)
CN (1) CN1596113B (cg-RX-API-DMAC7.html)
CA (1) CA2464471C (cg-RX-API-DMAC7.html)
MX (1) MXPA04004059A (cg-RX-API-DMAC7.html)
NO (1) NO20042257L (cg-RX-API-DMAC7.html)
PL (1) PL371297A1 (cg-RX-API-DMAC7.html)
RU (1) RU2314809C2 (cg-RX-API-DMAC7.html)
TW (1) TW200300089A (cg-RX-API-DMAC7.html)
WO (1) WO2003037342A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269805C (zh) * 2001-05-18 2006-08-16 阿斯特拉曾尼卡有限公司 4－(苯基－哌嗪基－甲基)－苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用
US8476280B2 (en) * 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203300D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US7314880B2 (en) * 2003-01-02 2008-01-01 Mount Cook Biosciences, Inc. Cardioprotective delta opioid receptor agonists and methods of using same
NZ593444A (en) 2003-10-01 2012-12-21 Adolor Corp 4-[(2-N,N-diethylaminocarbonyl)pyrid-5-yl]-spiro[1,2-dihydronaphthalene-2,4'-piperidine] and methods of its use
MX2007001240A (es) * 2004-08-02 2007-03-23 Astrazeneca Ab Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas.
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7683168B2 (en) * 2005-04-14 2010-03-23 Mount Cook Bio Sciences, Inc. Compositions of novel opioid compounds and method of use thereof
TW200803856A (en) 2005-09-02 2008-01-16 Mount Cook Biosciences Inc Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
NZ590041A (en) * 2008-05-20 2012-11-30 Astrazeneca Ab Method of treating anxious major depressive disorder
CN103467460A (zh) * 2013-09-23 2013-12-25 昆明理工大学 一类含噻吩环和苄基的二芳基甲基哌嗪化合物及其应用
CN105646151B (zh) * 2016-02-26 2018-06-29 山西大学 一种炔类化合物及其制备方法和该化合物的用途
WO2017173067A1 (en) 2016-03-31 2017-10-05 Versi Group, Llc Delta opioid agonist, mu opioid antagonist compositions and methods for treating parkinson's disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5681830A (en) * 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US20020052007A1 (en) * 1992-02-03 2002-05-02 Chang Kwen Jen Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
AU692788B2 (en) * 1993-07-30 1998-06-18 Ardent Pharmaceuticals, Inc. Piperazine compounds used in therapy
US6046200A (en) * 1994-09-09 2000-04-04 The United States Of America As Represented By The Secretary Of The Army Compositions having neuroprotective and analgesic activity
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
GB9709972D0 (en) * 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds
ATE273970T1 (de) * 1998-04-16 2004-09-15 Pfizer Prod Inc N-acyl und n-aroyl aralkylamide
SE9904673D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904675D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
GB0017256D0 (en) * 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
CN1269805C (zh) 2001-05-18 2006-08-16 阿斯特拉曾尼卡有限公司 4－(苯基－哌嗪基－甲基)－苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用

Similar Documents

Publication Publication Date Title
JP2005508363A5 (cg-RX-API-DMAC7.html)
JP6931019B2 (ja) 多発性硬化症を処置するためのｓ１ｐ受容体モジュレーター
JP2003503450A5 (cg-RX-API-DMAC7.html)
RU2314809C2 (ru) Способ лечения депрессии соединениями-агонистами дельта-рецепторов
RU2010126063A (ru) Производные 4-(2-амино-1-гидроксиэтил)фенола как агонисты в2 адренергического рецептора
JP2002542287A (ja) 医 薬
JP2007500238A5 (cg-RX-API-DMAC7.html)
JP2003506485A (ja) 肥満治療を意図した薬剤の製造のためのモノアミンオキシダーゼ阻害剤の使用
JP2009526821A (ja) 注意欠陥多動性障害治療用の新規な医薬組成物
CN1711087A (zh) 用于治疗眼新生血管性或水肿性紊乱和疾病的组蛋白脱乙酰酶抑制剂
CN101203217A (zh) 调节膀胱功能的方法
KR20070083826A (ko) 우울증을 위한 부가 요법
JP7592007B2 (ja) 睡眠時無呼吸の治療のためのα２‐アドレナリン受容体サブタイプＣ （ＡＬＰＨＡ‐２Ｃ）拮抗薬
JP3096306B2 (ja) 新規な治療方法
US6849654B2 (en) 5-methoxy-carbonylamino-N-acetyltryptamine compounds and derivates thereof
JP2006516643A5 (cg-RX-API-DMAC7.html)
JP2018203774A (ja) 精神障害の治療における使用のためのイロペリドン代謝物
JP2006510632A5 (cg-RX-API-DMAC7.html)
JP2010514682A5 (cg-RX-API-DMAC7.html)
JP2002541190A (ja) 気分障害治療用医薬を製造するためのオサネタントの使用
JP2011088919A (ja) アゴメラチンとノルアドレナリン再取り込み阻害剤との新たな組み合わせ、及びそれを含有している医薬組成物
JP2004262812A (ja) 眼圧低下剤
JP2002524509A (ja) 新規組成物
CA3139357A1 (en) Arylquinoziline derivatives as alpha2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea
TW200534848A (en) 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders